DAWN Q1 2022 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

DAWNDay One Biopharmaceuticals, Inc.

$2B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$6,000

Operating Income

-$28M

Net Income

-$28M

EPS (Diluted)

$-0.48

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$268M

Total Liabilities

$8M

Stockholders' Equity

$260M

Cash & Equivalents

$263M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6,000	-$49,000	+87.8%
Operating Income	-$28M	-$16M	-72.5%
Net Income	-$28M	-$15M	-82.8%